CN112708636A - 基因转录框架、载体系统、基因组序列编辑方法及应用 - Google Patents

基因转录框架、载体系统、基因组序列编辑方法及应用 Download PDF

Info

Publication number
CN112708636A
CN112708636A CN202110089068.1A CN202110089068A CN112708636A CN 112708636 A CN112708636 A CN 112708636A CN 202110089068 A CN202110089068 A CN 202110089068A CN 112708636 A CN112708636 A CN 112708636A
Authority
CN
China
Prior art keywords
sequence
gene
interspersed
vector
orf2p
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110089068.1A
Other languages
English (en)
Chinese (zh)
Inventor
彭双红
隋云鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110089068.1A priority Critical patent/CN112708636A/zh
Publication of CN112708636A publication Critical patent/CN112708636A/zh
Priority to KR1020237028513A priority patent/KR20230135630A/ko
Priority to JP2023541700A priority patent/JP2024504592A/ja
Priority to EP21920753.7A priority patent/EP4282968A4/en
Priority to AU2021422067A priority patent/AU2021422067A1/en
Priority to US18/266,592 priority patent/US20250263737A1/en
Priority to PCT/CN2021/134710 priority patent/WO2022156378A1/zh
Priority to MX2023008635A priority patent/MX2023008635A/es
Priority to BR112023014382A priority patent/BR112023014382A2/pt
Priority to CA3206081A priority patent/CA3206081A1/en
Priority to ZA2023/08025A priority patent/ZA202308025B/en
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Management Or Editing Of Information On Record Carriers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202110089068.1A 2021-01-22 2021-01-22 基因转录框架、载体系统、基因组序列编辑方法及应用 Pending CN112708636A (zh)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CN202110089068.1A CN112708636A (zh) 2021-01-22 2021-01-22 基因转录框架、载体系统、基因组序列编辑方法及应用
CA3206081A CA3206081A1 (en) 2021-01-22 2021-12-01 Gene transcription framework, vector system, genome sequence editing method and application
AU2021422067A AU2021422067A1 (en) 2021-01-22 2021-12-01 Gene transcription framework, vector system, genome sequence editing method and application
JP2023541700A JP2024504592A (ja) 2021-01-22 2021-12-01 遺伝子転写フレームワーク、ベクターシステム、ゲノム配列編集方法および応用
EP21920753.7A EP4282968A4 (en) 2021-01-22 2021-12-01 GENE TRANSCRIPTION FRAMEWORK, VECTOR SYSTEM, GENOME SEQUENCE EDITING METHOD AND APPLICATION
KR1020237028513A KR20230135630A (ko) 2021-01-22 2021-12-01 유전자 전사 프레임워크, 벡터 시스템, 게놈 서열 편집 방법 및 응용
US18/266,592 US20250263737A1 (en) 2021-01-22 2021-12-01 Gene transcription framework, vector system, genome sequence editing method and application
PCT/CN2021/134710 WO2022156378A1 (zh) 2021-01-22 2021-12-01 基因转录框架、载体系统、基因组序列编辑方法及应用
MX2023008635A MX2023008635A (es) 2021-01-22 2021-12-01 Marco para la transcripción de genes, sistema de vectores, método para editar la secuencia genómica y aplicación.
BR112023014382A BR112023014382A2 (pt) 2021-01-22 2021-12-01 Estrutura de transcrição gênica, sistema vetorial, método de edição da sequência do genoma e aplicação
ZA2023/08025A ZA202308025B (en) 2021-01-22 2023-08-18 Gene transcription framework, vector system, genome sequence editing method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110089068.1A CN112708636A (zh) 2021-01-22 2021-01-22 基因转录框架、载体系统、基因组序列编辑方法及应用

Publications (1)

Publication Number Publication Date
CN112708636A true CN112708636A (zh) 2021-04-27

Family

ID=75550451

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110089068.1A Pending CN112708636A (zh) 2021-01-22 2021-01-22 基因转录框架、载体系统、基因组序列编辑方法及应用

Country Status (11)

Country Link
US (1) US20250263737A1 (https=)
EP (1) EP4282968A4 (https=)
JP (1) JP2024504592A (https=)
KR (1) KR20230135630A (https=)
CN (1) CN112708636A (https=)
AU (1) AU2021422067A1 (https=)
BR (1) BR112023014382A2 (https=)
CA (1) CA3206081A1 (https=)
MX (1) MX2023008635A (https=)
WO (1) WO2022156378A1 (https=)
ZA (1) ZA202308025B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112481259A (zh) * 2020-11-24 2021-03-12 南昌大学 两种甘薯U6基因启动子IbU6的克隆与应用
CN115044583A (zh) * 2022-03-21 2022-09-13 隋云鹏 用于基因编辑的rna框架和基因编辑方法
CN115312121A (zh) * 2022-09-29 2022-11-08 北京齐碳科技有限公司 靶基因位点检测方法、装置、介质及程序产品

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102080101A (zh) * 2010-11-25 2011-06-01 北京济福霖生物技术有限公司 一种定点整合外源基因的方法
WO2016030501A1 (en) * 2014-08-28 2016-03-03 Centre National De La Recherche Scientifique - Cnrs - Synthetic alu-retrotransposon vectors for gene therapy
US20190153528A1 (en) * 2016-02-12 2019-05-23 Jumpcode Genomics, Inc. Method for target specific rna transcription of dna sequences
US20200109398A1 (en) * 2018-08-28 2020-04-09 Flagship Pioneering, Inc. Methods and compositions for modulating a genome
CN112210573A (zh) * 2020-10-14 2021-01-12 浙江大学 一种用基因编辑改造原代细胞的dna模板及定点插入方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2281050B1 (en) * 2008-04-14 2014-04-02 Sangamo BioSciences, Inc. Linear donor constructs for targeted integration
US20210340562A1 (en) * 2018-10-19 2021-11-04 Board Of Regents, The University Of Texas System Engineered long interspersed element (line) transposons and methods of use
JP7831937B2 (ja) * 2019-09-03 2026-03-17 クリエイト・メディシンズ，インコーポレーテッド ゲノム組込みのための方法および組成物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102080101A (zh) * 2010-11-25 2011-06-01 北京济福霖生物技术有限公司 一种定点整合外源基因的方法
WO2016030501A1 (en) * 2014-08-28 2016-03-03 Centre National De La Recherche Scientifique - Cnrs - Synthetic alu-retrotransposon vectors for gene therapy
US20190153528A1 (en) * 2016-02-12 2019-05-23 Jumpcode Genomics, Inc. Method for target specific rna transcription of dna sequences
US20200109398A1 (en) * 2018-08-28 2020-04-09 Flagship Pioneering, Inc. Methods and compositions for modulating a genome
CN112210573A (zh) * 2020-10-14 2021-01-12 浙江大学 一种用基因编辑改造原代细胞的dna模板及定点插入方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PRESCOTT DEININGER: "Alu elements: know the SINEs", 《GENOME BIOLOGY》 *
YIFAN WANG等: "BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance", 《NATURE COMMUNICATION》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112481259A (zh) * 2020-11-24 2021-03-12 南昌大学 两种甘薯U6基因启动子IbU6的克隆与应用
CN112481259B (zh) * 2020-11-24 2022-09-16 南昌大学 两种甘薯U6基因启动子IbU6的克隆与应用
CN115044583A (zh) * 2022-03-21 2022-09-13 隋云鹏 用于基因编辑的rna框架和基因编辑方法
WO2023179132A1 (zh) * 2022-03-21 2023-09-28 隋云鹏 用于基因编辑的rna框架和基因编辑方法
CN115312121A (zh) * 2022-09-29 2022-11-08 北京齐碳科技有限公司 靶基因位点检测方法、装置、介质及程序产品

Also Published As

Publication number Publication date
EP4282968A4 (en) 2024-12-04
JP2024504592A (ja) 2024-02-01
BR112023014382A2 (pt) 2023-10-31
US20250263737A1 (en) 2025-08-21
ZA202308025B (en) 2024-03-27
CA3206081A1 (en) 2022-07-28
AU2021422067A1 (en) 2023-09-07
KR20230135630A (ko) 2023-09-25
MX2023008635A (es) 2023-10-17
EP4282968A1 (en) 2023-11-29
WO2022156378A1 (zh) 2022-07-28

Similar Documents

Publication Publication Date Title
AU2020259548B2 (en) Methods and compositions for editing RNAs
CN115651927B (zh) 编辑rna的方法和组合物
US20230125704A1 (en) Modified bacterial retroelement with enhanced dna production
CN112708636A (zh) 基因转录框架、载体系统、基因组序列编辑方法及应用
JP2013509168A (ja) 心臓特異的核酸調節因子ならびにこの方法および使用
JP2023073997A (ja) 循環ｒｎａプラットフォーム、その用途、および操作されたｄｎａからの製造プロセス
WO2004113867A2 (en) Exon analysis
CN119630788A (zh) 可编程腺嘌呤碱基编辑器及其用途
Watanabe et al. RNA repair: a novel approach to gene therapy
US20250215422A1 (en) RT-DNA Fidelity and Retron Genome Editing
US20250197883A1 (en) Rna framework for gene editing and gene editing method
CN121079413A (zh) 编辑rna的方法、组合物及其应用
US6410228B1 (en) Method for the identification of synthetic cell- or tissue- specific transcriptional regulatory regions
WO2023018938A1 (en) Methods for generation of precise rna transcripts
WO2024020114A2 (en) Genome insertions in cells
WO2023183627A1 (en) Production of reverse transcribed dna (rt-dna) using a retron reverse transcriptase from exogenous rna
KR20230142576A (ko) 스터퍼 폴리뉴클레오티드 서열을 포함하는 벡터
CN116648505A (zh) 包含靶向b2m的rna指导物的组合物及其用途
WO2024213138A1 (en) Guide nucleic acids targeting vegfa and uses thereof
CN121136977A (zh) Rna环化核酸分子及其应用
JP2025533501A (ja) ポンペ病マウスモデルの生成、特徴決定および使用方法
HK40061041A (en) Methods and compositions for editing rnas
HK40081918B (en) Methods and compositions for editing rna
EP4692346A1 (en) Crrna having modified nucleotide
KR20260054711A (ko) II형 Cas 단백질, CRISPR-Cas 시스템 및 이의 용도

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination